Bioorganic and Medicinal Chemistry Letters p. 1077 - 1082 (1998)
Update date:2022-08-02
Topics:
Patel, Mona
Kaltenbach III, Robert F.
Nugiel, David A.
McHugh Jr., Robert J.
Jadhav, Prabhakar K.
Bacheler, Lee T.
Cordova, Beverly C.
Klabe, Ronald M.
Erickson-Viitanen, Susan
Garber, Sena
Reid, Carol
Seitz, Steven P.
Cyclic urea SD 146, a potent HIV protease inhibitor bearing a flat resistance profile, possessed poor solubility and bioavailability, which precluded further development of the compound. In an effort to improve upon the pharmacokinetic profile of the compound, several analogs modified at the P1/P1' residues were prepared and evaluated. Several of those compounds displayed significant improvement of physical properties.
View Morewebsite:http://www.oceanchem-group.com
Contact:86-536-8596048
Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
Zhejiang Rongkai Chemical Technology Co.,Ltd.
Contact:+86-578-8185786
Address:Shangjiang Industrial Zone,Suichang
Chongqing Yawei Fine Chemical Co.,Ltd
Contact:0086-23-62849407
Address:Ziyou village, Nanquan town, Banan district, Chongqing China
Shanghai Hanhong Scientific Co.,Ltd.
website:http://www.chemvia.com
Contact:+86-21-64541543,54280654,13918533501
Address:Jiachuan Road 245
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Doi:10.1039/C1968001400b
(1968)Doi:10.1021/ic50022a024
(1964)Doi:10.1021/om980222u
(1998)Doi:10.1021/jp981158x
(1998)Doi:10.1021/jo0478609
(2005)Doi:10.1021/ja01464a040
(1961)
